Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

March 28, 2017

Primary Completion Date

February 7, 2019

Study Completion Date

March 23, 2021

Conditions
Plaque Psoriasis
Interventions
DRUG

Ixekizumab

Administered SC

DRUG

Placebo

Administered SC

DRUG

Etanercept

Administered SC

Trial Locations (69)

1123

Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak, Budapest

3100

RM Pharma Specialists S.A. de C.V., Distrito Federal

4032

Debreceni Egyetem Klinikai Kozpont Borgyogyaszati Klinika, Debrecen

5000

Allergo-Derm Bakos Kft, Szolnok

5200

Fundación Estudios Clínicos- Servicio de Dermatología, Rosario

5901

Oroshaza Varosi Onkormanyzat Korhaza, Orosháza

6720

SZTE AOK Borgyogyaszati es Allergologiai Klinika, Szeged

10789

ISA GmbH, Berlin

19341

Dermatology and Skin Surgery Center, Exton

20010

Children's National Medical Center, Washington D.C.

23502

Virginia Clinical Research, Norfolk

27516

University of North Carolina Dermatology and skin Cancer Cen, Chapel Hill

28041

Hospital Universitario 12 de Octubre, Madrid

28046

Hospital Universitario La Paz, Madrid

29425

Medical University of South Carolina, Charleston

30328

Advanced Medical Research, Sandy Springs

32256

Solutions Through Advanced Research, Inc., Jacksonville

33076

Centre hospitalier universitaire Pellegrin, Bordeaux

33612

University of South Florida, Tampa

33624

Forward Clinical Trials, Inc, Tampa

33756

Olympian Clinical Research, Clearwater

35233

University of Alabama at Birmingham, Birmingham

43230

Ohio State Univ College Of Medicine, Gahanna

45324

Wright State Physicians Dermatology, Fairborn

46617

The South Bend Clinic, South Bend

48149

Universitätsklinikum Münster, Münster

55131

Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz

60008

Arlington Dermatology, Rolling Meadows

60590

Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt am Main

60611

Northwestern University, Chicago

60637

University of Chicago Medical Center, Chicago

63104

SSM Health Cardinal Glennon Children's Hospital, St Louis

64460

Hospital Univ. Dr. Jose Eleuterio Gonzalez, Monterrey

65212

University of Missouri, Columbia

69500

Hôpital Femme Mère Enfant, Bron

75231

Modern Research Associates PLLC, Dallas

78218

Texas Dermatology and Laser Specialists, San Antonio

91054

Universitätsklinikum Erlangen, Erlangen

91910

Arke Estudios Clinicos S.A. de C.V., Veracruz

92708

Tien Q. Nguyen, MD inc. DBA First OC Dermatology, Fountain Valley

97210

Oregon Dermatology and Research Center, Portland

97239

Oregon Health and Science University, Portland

119991

Center of Children's Health, Moscow

350000

GBUZ Clinical dermatology and venereological dispensary, Krasnodar

08520

Psoriasis Treatment Center of Central New Jersey, East Windsor

C1056ABJ

Centro de Investigaciones Metabólicas (CINME), Ciudad Autonoma de Buenos Aire

C1425BEA

Instituto de Neumonología y Dermatología, Buenos Aires

C1425DKG

Psoriahue Medicina Interdisciplinaria, Buenos Aires

T3A 2N1

Institute for Skin Advancement, Calgary

L3P1X2

Lynderm Research Inc, Markham

N2J 1C4

K. Papp Clinical Research Inc, Waterloo

H3T 1C5

Hospital Ste Justine, Montreal

613 00

Detska fakultni nemocnice, Brno

500 05

Fakultni nemocnice Hradec Kralove, Hradec Králové

305 99

Fakultni Nemocnice Plzen, Plzen-Bory

100 34

Fakultni nemocnice Kralovske Vinohrady, Prague

120 00

LF UK - Fakultni poliklinika, Prague

180 81

Nemocnice Na Bulovce, Prague

06202

CHU de Nice Hopital de L'Archet, Nice

06720

Hospital Infantil de Mexico, Mexico City

6525 GL

Universitair Medisch Centrum St Radboud Nijmegen, Nijmegen

90-265

"Dermed Centrum Medyczne Sp. z o.o.", Lodz

02-507

Centralny Szpital Kliniczny MSW, Warsaw

51-318

DermMEDICA Sp. z o.o., Wroclaw

00727

Office of Dr. Samuel Sanchez PSC, Caguas

00985

Grupo Dermatologico de Carolina, Carolina

00716

Ponce School of Medicine CAIMED Center, Ponce

00917

GCM Medical Group PSC, San Juan

08950

Hospital Sant Joan de Déu, Esplugues de Llobregat

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03073200 - Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis | Biotech Hunter | Biotech Hunter